| __timestamp | Dr. Reddy's Laboratories Limited | Galapagos NV |
|---|---|---|
| Wednesday, January 1, 2014 | 12402000000 | 111110000 |
| Thursday, January 1, 2015 | 17449000000 | 129714000 |
| Friday, January 1, 2016 | 17834000000 | 139574000 |
| Sunday, January 1, 2017 | 19551000000 | 218502000 |
| Monday, January 1, 2018 | 18265000000 | 322876000 |
| Tuesday, January 1, 2019 | 15607000000 | 427320000 |
| Wednesday, January 1, 2020 | 15410000000 | 523667000 |
| Friday, January 1, 2021 | 16541000000 | 491707000 |
| Saturday, January 1, 2022 | 17482000000 | 515083000 |
| Sunday, January 1, 2023 | 19381000000 | 241294000 |
| Monday, January 1, 2024 | 22873000000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Dr. Reddy's Laboratories Limited and Galapagos NV, two prominent players, have shown distinct approaches in their R&D investments over the past decade. From 2014 to 2023, Dr. Reddy's consistently allocated a significant portion of its resources to R&D, with expenditures peaking at approximately 22.9 billion in 2024. This represents a robust 84% increase from their 2014 spending. In contrast, Galapagos NV's R&D spending, while more modest, saw a remarkable growth of nearly 370% from 2014 to 2022, before a notable decline in 2023. This divergence highlights the strategic priorities of each company, with Dr. Reddy's maintaining a steady investment trajectory, while Galapagos NV experienced more volatility. The absence of data for Galapagos NV in 2024 suggests a potential shift or reevaluation in their R&D strategy.
Comparing Innovation Spending: Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited
Comparing Innovation Spending: Gilead Sciences, Inc. and Galapagos NV
Research and Development Expenses Breakdown: Teva Pharmaceutical Industries Limited vs Dr. Reddy's Laboratories Limited
Research and Development Investment: Teva Pharmaceutical Industries Limited vs Galapagos NV
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Blueprint Medicines Corporation
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and TG Therapeutics, Inc.
Research and Development Investment: Dr. Reddy's Laboratories Limited vs Protagonist Therapeutics, Inc.
Dr. Reddy's Laboratories Limited vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: BioMarin Pharmaceutical Inc. vs Galapagos NV
R&D Spending Showdown: Madrigal Pharmaceuticals, Inc. vs Galapagos NV
ACADIA Pharmaceuticals Inc. vs Galapagos NV: Strategic Focus on R&D Spending
R&D Spending Showdown: Mesoblast Limited vs Galapagos NV